The American Society of Clinical Oncology published a position statement on state drug repository programs, outlining ASCO’s support for drug repository programs solely for oral medications, provided they are maintained within a closed system.
To access this subscriber-only content please log in or subscribe.
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe
If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.
Login Subscribe